Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 121-130 of 189 for

Edit search filters
  1. A Study Of MCLA-128 In Patients With Solid Tumors Harboring An NRG1 Fusion

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study To Evaluate MUC1 Vaccine To Prevent Lung Cancer In Current And Former Smokers At High Risk For Lung Cancer

    Rochester, MN

  3. Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer Patients

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Pembrolizumab With Or Without Anetumab Ravtansine In Treating Patients With Mesothelin-Positive Pleural Mesothelioma

    Jacksonville, FL, Rochester, MN

  5. Study Of Pembrolizumab With Ipilimumab Or Placebo In Participants With Untreated Metastatic Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  6. A Study To Evaluate Exercise For Cancer Patients At Risk Of Falling

    Rochester, MN

  7. Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy In Previously Treated Advanced Or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations Or Other Genomic Alterations (MK-2870-004)

    Jacksonville, FL, Rochester, MN

  8. A Study To Evaluate Stereotactic Radiosurgery Versus Hippocampal-Avoidant Whole Brain Radiotherapy For 10 Or Fewer Brain Metastases From Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  9. Study Of BLU-667 In Patients With Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) And Other Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study To Assess The Effectiveness Of Osimertinib Plus Savolitinib In Patients With Locally Advanced Or Metastatic Non Small Cell Lung Cancer Who Have Progressed Following Osimertinib Treatment (SAVANNAH Study) Following Prior Osimertinib

    Rochester, MN

.

Mayo Clinic Footer